Xponance’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
19,621
+7,971
+68% +$867K 0.02% 504
2026
Q1
$1.08M Buy
11,650
+2,020
+21% +$203K 0.01% 725
2025
Q4
$984K Buy
9,630
+199
+2% +$17.8K 0.01% 692
2025
Q3
$589K Buy
9,431
+87
+0.9% +$4.73K ﹤0.01% 906
2025
Q2
$486K Buy
9,344
+228
+3% +$10.2K ﹤0.01% 963
2025
Q1
$388K Buy
9,116
+582
+7% +$25.1K ﹤0.01% 1010
2024
Q4
$261K Buy
+8,534
New +$240K ﹤0.01% 1177
2024
Q3
Sell
-7,479
Closed -$216K 1392
2024
Q2
$216K Buy
+7,479
New +$174K ﹤0.01% 1160
2023
Q3
Sell
-6,545
Closed -$234K 1254
2023
Q2
$234K Sell
6,545
-6,953
-52% -$200K ﹤0.01% 1113
2023
Q1
$316K Buy
13,498
+461
+4% +$13.2K ﹤0.01% 1030
2022
Q4
$355K Buy
13,037
+1,398
+12% +$64K 0.01% 1003
2022
Q3
$627K Buy
11,639
+269
+2% +$13.8K 0.01% 748
2022
Q2
$459K Buy
11,370
+1,051
+10% +$52.1K 0.01% 883
2022
Q1
$684K Buy
10,319
+190
+2% +$13K 0.01% 757
2021
Q4
$1.01M Buy
10,129
+3
+0% +$310 0.02% 605
2021
Q3
$1.27M Sell
10,126
-195
-2% -$23.2K 0.02% 476
2021
Q2
$1.28M Buy
10,321
+1,837
+22% +$247K 0.02% 485
2021
Q1
$1.29M Sell
8,484
-43
-0.5% -$6.5K 0.03% 402
2020
Q4
$1.1M Buy
8,527
+792
+10% +$91.1K 0.02% 442
2020
Q3
$865K Sell
7,735
-32
-0.4% -$2.93K 0.02% 453
2020
Q2
$630K Buy
+7,767
New +$626K 0.02% 504

Other funds holding GH

Xponance's GH Position: Q2 2026 in Review

Xponance increased its Guardant Health (GH) stake by 68% in Q2 2026, buying an estimated $867K and bringing the position to 19,621 shares worth $2.94M. The position accounts for 0.02% of the portfolio, ranked #504.

Xponance first reported a position in GH in Q2 2020 and has held it in 21 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Xponance held 19,621 shares of Guardant Health worth $2.94M as of Q2 2026.
  • Xponance bought 7,971 Guardant Health shares in Q2 2026, an estimated $867K.
  • Guardant Health made up 0.02% of Xponance's portfolio in Q2 2026, its #504 holding.
  • Xponance first reported a position in Guardant Health in Q2 2020 and has held it in 21 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.